Im Cannabis Corp (TSE:IMCC) has released an update.
IM Cannabis Corp celebrates the start of a new era in Israel’s medical cannabis market with the April 1st regulatory reform, making it easier for patients to access treatments for a range of conditions. The reform eliminates the need for licenses, allows HMOs to prescribe cannabis, and is expected to increase the number of prescribing physicians and reduce prescription costs. This is anticipated to significantly expand the patient base, signaling a transformative shift in the Israeli medical cannabis industry.
For further insights into TSE:IMCC stock, check out TipRanks’ Stock Analysis page.
